Both in Pharmaceuticals
Pacira BioSciences vs Kailera Therapeutics
Over the past year PCRX returned +43.2% and KLRA returned −16.7%; their daily moves had a correlation of -0.21.
PCRX +43.2% KLRA −16.7%Growth of $1, one year, split-adjusted
| Metric | PCRX | KLRA |
|---|---|---|
| Price | $36.31 | $11.61 |
| Market cap | $1.45B | $1.51B |
| Today | −0.22% | +16.10% |
| 1 month | +44.3% | — |
| 6 months | +52.6% | — |
| Year to date | +40.3% | — |
| 1 year | +55.1% | — |
| Revenue growth (YoY) | +6.2% | — |
| Gross margin | 77.0% | — |
| Net margin | 2.4% | — |
| P/E (TTM) | 99.0× | — |
| Price / sales | 1.9× | — |
| Net cash | -$112.1M | $916.7M |
| Dividend yield | — | — |
| Volatility (60d) | 82.9% | — |
| Short % of float | 21.2% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).